Free Content Onset of action during on-demand treatment with Maalox suspension or low-dose ranitidine for heartburn

Authors: Faaij1; Van Gerven,1; Jolivet-Landreau2; Masclee3; Vendrig1; Schoemaker1; Jacobs4; Cohen1

Source: Alimentary Pharmacology & Therapeutics, Volume 13, Number 12, December 1999 , pp. 1605-1610(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Aim: 

To compare the onset of action of the local antacid Maalox and the systemic H2-antagonist ranitidine, during `on demand' ambulant treatment of a single heartburn episode, using a randomized, parallel group, double-blind, double-dummy design. Methods: 

Subjects with self-perceived heartburn without known gastrointestinal disease or interfering treatments were selected with questionnaires. The study was performed unsupervised, whenever heartburn required medication. An electronic patient diary gave instructions when to take study medication, and provided visual analogue scales and five-item relief ratings for heartburn, at frequent time intervals activated by an alarm-clock. Results: 

After a study of the natural history of heartburn and the feasibility of the study procedures in 23 patients, 49 subjects took Maalox and 45 ranitidine. Half of these experienced meaningful heartburn relief within 19 min after Maalox, and within 70 min after ranitidine. One hour after intake, the average heartburn relief score was 3.43 in the Maalox group and 3.04 in the ranitidine group (3 means `slight improvement' and 4 `strong improvement'). Heartburn was similar in both groups after 3 h. Conclusions: 

Maalox provides faster relief of heartburn than ranitidine. Heartburn can be assessed frequently and reliably under ambulant conditions using an electronic patient diary.

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1365-2036.1999.00654.x

Affiliations: 1: Centre for Human Drug Research (CHDR), Leiden, The Netherlands, 2: Rhône-Poulenc Théraplix, Paris, France, 3: Leiden University Medical Center, Department of Gastroenterology, Leiden, The Netherlands, 4: Rhône-Poulenc Rorer, Antony Cedex, France

Publication date: 1999-12-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page